{"title":"Doyne honeycomb retinal dystrophy with primary angle closure: a case report.","authors":"Chao Xu, Hejiang Ye","doi":"10.1007/s10633-026-10158-y","DOIUrl":"https://doi.org/10.1007/s10633-026-10158-y","url":null,"abstract":"<p><strong>Objective: </strong>To report a clinical case of Doyne honeycomb retinal dystrophy (DHRD) caused by an EFEMP1 gene mutation complicated by primary angle closure, and to discuss its clinical characteristics, reasons for misdiagnosis, and therapeutic challenges.</p><p><strong>Methods: </strong>The clinical data of a 53-year-old male patient were retrospectively analyzed. The patient presented with binocular metamorphopsia and decreased visual acuity persisting for over 9 years. He had been previously misdiagnosed with \"macular degeneration\" and \"macular edema\" and received corresponding treatments for a prolonged period. During the current consultation, multimodal fundus imaging (FFA/ICGA/OCT), ultrasound biomicroscopy (UBM), and ophthalmic genetic testing were performed.</p><p><strong>Results: </strong>Fundus examination and imaging revealed characteristic radial drusen in the posterior pole and nasal to the optic disc, retinal pigment epithelium (RPE) atrophy, and secondary choroidal neovascularization (CNV) in the macular region. Genetic testing identified a heterozygous c.1033C>T (p.Arg345Trp) variant in the EFEMP1 gene, confirming the diagnosis of DHRD. The patient was also diagnosed with primary angle closure due to bilateral angle closure/narrowing and initially underwent bilateral laser peripheral iridotomy (LPI). Subsequently, intravitreal injections of faricimab were administered for the secondary CNV. However, due to the advanced stage of the disease, severe disruption of retinal structures, and fibrosis, no significant improvement was observed in visual acuity or anatomical structure.</p><p><strong>Conclusion: </strong>The clinical manifestations of DHRD significantly overlap with age-related macular degeneration (AMD), leading to a high risk of misdiagnosis. For patients with early onset (< 50 years) and typical drusen nasal to the optic disc, genetic testing is crucial for confirmation. This case presents a rare concurrence of primary angle closure, differing from the previously reported association with open-angle glaucoma, which adds to the therapeutic complexity. Furthermore, the limited response observed in this patient may be attributed to the advanced atrophic and cicatricial macular changes, rather than indicating generalized resistance to anti-VEGF therapy in late-stage DHRD, highlighting the importance of early precise diagnosis and comprehensive management.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gabriela Chlebowska, Krzysztof Michalak, Ewa Gancek, Magdalena Lis, Monika Drzazga, Anna Lyp-Broszko, Tomasz Klaudel, Mateusz Strojek, Rafał Pławszewski
{"title":"Rare genetic variants in leber hereditary optic neuropathy: molecular mechanisms, diagnosis, and emerging therapies.","authors":"Gabriela Chlebowska, Krzysztof Michalak, Ewa Gancek, Magdalena Lis, Monika Drzazga, Anna Lyp-Broszko, Tomasz Klaudel, Mateusz Strojek, Rafał Pławszewski","doi":"10.1007/s10633-026-10166-y","DOIUrl":"https://doi.org/10.1007/s10633-026-10166-y","url":null,"abstract":"<p><p>Hereditary optic neuropathies, such as Leber's hereditary optic neuropathy (LHON), remain a focus of active research. Diagnostic challenges and severe clinical consequences often result in atypical presentations, creating significant obstacles for neuro-ophthalmology. The field has garnered increased attention due to advances in molecular biology and genetic engineering. Pathogenic variants in mitochondrial DNA (mtDNA) and nuclear DNA disrupt oxidative phosphorylation, reduce adenosine triphosphate production, and increase reactive oxygen species generation, to which retinal ganglion cells are particularly vulnerable. Rare genetic variants have been identified in LHON and related mitochondrial disorders, including mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes and Leigh syndrome. Phenotypic heterogeneity, variable heteroplasmy levels, and limited sensitivity of targeted genetic testing complicate the detection and interpretation of rare variants. As a result, comprehensive next-generation sequencing is increasingly necessary for accurate molecular diagnosis and timely treatment initiation. Recent therapeutic interventions include genotype-specific approaches, such as adeno-associated virus serotype 2-mediated allotopic expression, and genotype-independent therapies, such as idebenone. Diagnostic standards for mitochondrial optic neuropathies have shifted from focusing solely on the three primary pathogenic mtDNA variants to a broader molecular diagnostic framework. Future research should prioritize mtDNA sequencing in cases with inconclusive diagnoses using conventional methods, incorporate mitochondrial and nuclear genomics, and leverage artificial intelligence-based approaches. Accurate identification and classification of rare variants, together with a deeper understanding of their phenotypic consequences, will facilitate the development of individualized therapeutic strategies to prevent further visual decline. This review outlines potential directions for multifaceted treatment strategies in patients with rare LHON-associated variants and critically evaluates current evidence regarding the clinical significance of rare mitochondrial and nuclear genetic variants in LHON and related mitochondrial optic neuropathies.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuroprotective effects of ıdebenone and citicoline in experimental traumatic optic neuropathy: electrophysiological, histological, and biochemical assessments in a rat model.","authors":"Zarife Nurbanu Mendı, Pinar Nalcacıoglu Memis, Mualla Hamurcu, Pinar Oksuz, Salim Neselıoglu","doi":"10.1007/s10633-026-10156-0","DOIUrl":"https://doi.org/10.1007/s10633-026-10156-0","url":null,"abstract":"<p><p>OBJECTıVE: This study aims to investigate the neuroprotective efficacy of idebenone and citicoline in a rat model of traumatic optic neuropathy (TON), induced by controlled optic nerve (ON) crush injury. MATERıALS AND METHODS: Forty male Wistar rats (250-300 g) were randomly assigned to four groups (n=10). TON was induced in Groups 1, 2 and 3 via right ON crush. Group 1 received no treatment; Group 2 received idebenone (50 mg/kg/day), and Group 3 received citicoline (1 g/kg/day) via a nasogastric tube, starting 24 h post-injury. Group 4 served as sham controls. Flash and pattern visual evoked potentials (fVEP, pVEP) were recorded at baseline, 48 h, and day 28. The flash and pattern VEP tests were performed using the MonPackONE device. Blood biomarkers (ischemia-modified albumin (IMA), total and native thiol) were analyzed, and histological evaluations included hematoxylin-eosin (H&E) staining and glial fibrillary acidic protein (GFAP) monoclonal antibody immunohistochemistry. RESULTS: At day 2, VEP tests indicated delayed latency and decreased amplitude in Groups 1-3 versus the sham group. By day 28, Groups 2 and 3 showed significant VEP improvement over Group 1. Biochemical analysis demonstrated higher thiol levels in Group 3 compared to Group 2 on day 28; however, this difference was not statistically significant. GFAP staining in the retina and ON tissues was highest in Group 1 and lowest in Group 4. ON thickness was greater in Group 2 than in Group 3, but the difference was also not statistically significant. CONCLUSıON: Although neither treatment demonstrated superiority over the other, both oral citicoline and idebenone provided neuroprotection in TON, as evidenced by improved electrophysiological function, greater retina ganglion cell survival, and elevated systemic antioxidant markers.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abstracts of the 63rd Annual Symposium of the International Society for Clinical Electrophysiology of Vision (ISCEV 2026), Sydney, Australia.","authors":"","doi":"10.1007/s10633-026-10133-7","DOIUrl":"10.1007/s10633-026-10133-7","url":null,"abstract":"","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":"5-43"},"PeriodicalIF":2.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148561013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Guest Editorial: ISCEV Symposium 2026 Sydney Australia.","authors":"Elisa E Cornish, John R Grigg","doi":"10.1007/s10633-026-10155-1","DOIUrl":"10.1007/s10633-026-10155-1","url":null,"abstract":"","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":"1-3"},"PeriodicalIF":2.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Static and dynamic characteristics of the pupil light reflex obtained in Indian eyes using a hand-held, objective pupillometer.","authors":"Erum Nisha, Rahul Negi, Tithi Halder, Manasa Kalivemula, Nabeel Quadri, Ayush Kumar, Manjushree Bhate, Virender Sachdeva, Shrikant R Bharadwaj","doi":"10.1007/s10633-026-10160-4","DOIUrl":"https://doi.org/10.1007/s10633-026-10160-4","url":null,"abstract":"<p><strong>Purpose: </strong>To establish the baseline data of static and dynamic characteristics of the pupil light reflex in Indian eyes across a wide age range using Pupil N, a newly developed handheld, objective pupillometer and thereby compare the present outcomes with a comparable dataset in Indian eyes obtained using the NPi-200, the current standard of care in objective pupillometry.</p><p><strong>Methods: </strong>Pupil N elicits the light reflex by delivering two 1-s-long visible light pulses of 125 lx intensity onto the eye with 4-s of interstimulus interval, all after initial 6-s of dark adaptation. Pupil diameters recorded using an infrared sensitive camera (30 fps) are processed using a commercial smartphone to derive six outcome variables: pre- and post-stimulated diameter, miosis (normalized to pre-stimulation values), constriction and dilation peak velocities and response latency. Baseline data were collected in this study in both eyes on 290 healthy participants (3-86 years of age) and the right eye data of adults were compared with those obtained using NPi-200 by Rattan et al. [37].</p><p><strong>Results: </strong>Baseline values calculated for each age decade showed younger eyes having larger pre-and post-stimulation diameters, faster constriction and dilation peak velocities, relative to older eyes (p < 0.001). The magnitude of miosis and response latency were similar across ages, except for larger miosis and shorter latencies in the first decade of life (p < 0.001). Data trends were similar to Rattan et al., but the absolute values differed across outcome variables (p < 0.001), except for pre-stimulation diameter (p = 0.06).</p><p><strong>Conclusions: </strong>The baseline values of pupil light reflex reported here for Pupil N may be used as future reference standards for interpreting data of individuals with neurological dysfunction. The inter-device differences reported here call for caution while using these devices interchangeably for eliciting/interpreting the pupil light reflex in clinical and research environments.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149295443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unilateral retinal bipolar cell dysfunction with photophobia.","authors":"Miku Kurata, Keiko Kataoka, Mariko Kumagai, Annabelle A Okada, Akito Hirakata, Yozo Miyake","doi":"10.1007/s10633-026-10167-x","DOIUrl":"https://doi.org/10.1007/s10633-026-10167-x","url":null,"abstract":"<p><strong>Purpose: </strong>To report a patient with unilateral photophobia but unremarkable multimodal imaging, in whom a negative electroretinogram (ERG) indicated retinal bipolar cell dysfunction, and both the photophobia and the ERG later improved in part.</p><p><strong>Methods: </strong>Single case report. Examinations included best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, color fundus photography, optical coherence tomography (OCT), fundus autofluorescence (FAF), color vision testing, Goldmann and Humphrey perimetry, full-field ERG, multifocal ERG (mfERG), and photopic On-Off ERG, with 3-year follow-up.</p><p><strong>Results: </strong>A 67-year-old man had a 3-year history of subacute photophobia and central blurring in the left eye that had remained undiagnosed at several institutions. At the initial visit to our hospital, BCVA was 1.2 in decimal in both eyes. Color fundus photography, OCT, FAF, color vision, and perimetry showed no relevant abnormality. Full-field ERG was normal in the right eye; the left eye showed a reduced dark-adapted (DA) 0.01 ERG, a negative DA 3 ERG with a preserved a-wave (b:a ratio = 0.53), mildly reduced oscillatory potentials, and severely reduced light-adapted (LA) 3 and LA 30 Hz ERGs. The mfERG was preserved centrally and reduced peripherally. At 4 years from onset, the photophobia improved, and the b:a ratio of the DA 3 ERG increased to 0.90, with slight recovery of the LA 30 Hz ERG. At 5 and 6 years from onset, the DA 0.01, LA 3, and LA 30 Hz ERGs showed slight further improvement, and the b:a ratio of the DA 3 ERG increased to 1.07 and 1.62, respectively, whereas the photophobia was unchanged.</p><p><strong>Conclusions: </strong>Unilateral On- and Off-bipolar cell dysfunction presenting as photophobia can show partial improvement. The ERG is essential for diagnosis and objective monitoring.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149295405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Doğa Akay Salihoğlu, Mehmet Erkan Doğan, Yusuf Akar
{"title":"Impact of Anti-VEGF treatment on retinal anatomy and electrophysiological function in diabetic macular edema.","authors":"Doğa Akay Salihoğlu, Mehmet Erkan Doğan, Yusuf Akar","doi":"10.1007/s10633-026-10163-1","DOIUrl":"https://doi.org/10.1007/s10633-026-10163-1","url":null,"abstract":"<p><strong>Purpose: </strong>The objective of this study is to evaluate changes in the foveal avascular zone (FAZ), vascular density (VD), and electrophysiological parameters in patients with diabetic macular edema (DME) following intravitreal bevacizumab therapy.</p><p><strong>Methods: </strong>The study comprised 27 eyes of 22 patients with treatment-naive DME who received a loading phase of three consecutive monthly intravitreal bevacizumab injections, together with 30 eyes of 15 healthy controls. All participants underwent optical coherence tomography (OCT), OCT angiography (OCTA), pattern electroretinography (PERG) and visual evoked potentials (VEP) at baseline and at one and three months. As both eyes of some participants were included, all comparisons used generalized estimating equations clustered on subject, with cluster-robust variance estimation.</p><p><strong>Results: </strong>Central retinal thickness decreased significantly after treatment, from 409.2 ± 105.9 µm at baseline to 368.4 ± 97.8 µm at 1 month (p = 0.007) and 352.6 ± 93.6 µm at 3 months (p < 0.001). Best-corrected visual acuity improved from 0.69 ± 0.47 to 0.57 ± 0.44 logMAR, but this change did not reach statistical significance (p = 0.166). FAZ measurements showed no significant change at either visit (all p > 0.57) and superficial VD remained stable (p = 0.404 and p = 0.185), whereas measured deep VD increased significantly at both 1 month (+ 1.02%, p = 0.045) and 3 months (+ 1.85%, p = 0.002), a change that may reflect improved OCTA signal penetration after edema resolution rather than true reperfusion. The 100% contrast response magnitude increased at 3 months (p = 0.040) but not at 1 month (p = 0.293), and did not retain significance after adjustment for multiple comparisons. Lc and Hc amplitudes increased significantly at 3 months (p = 0.021 and p < 0.001), whereas latencies remained prolonged relative to controls at baseline (Lc, p = 0.001; Hc, p = 0.004).</p><p><strong>Conclusion: </strong>Intravitreal bevacizumab therapy in treatment-naive DME patients produced significant anatomical improvement, accompanied by changes in selected electrophysiological parameters. The stability of FAZ measurements, the apparent increase in deep VD, and the improved VEP amplitudes, in the absence of concurrent normalisation of latency, suggest that structural, microvascular and functional recovery may follow different time courses. This indicates that anatomical response alone may overestimate functional benefit. The electrophysiological changes observed were modest and require confirmation in larger cohorts.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149285811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From stimulus timing to real-world clinical peak time distributions: CRT versus LCD pattern-reversal VEP.","authors":"Yuichiro Shirota, Megumi Akita, Tomoyuki Mochida, Katsura Masaki","doi":"10.1007/s10633-026-10164-0","DOIUrl":"https://doi.org/10.1007/s10633-026-10164-0","url":null,"abstract":"<p><strong>Purpose: </strong>This study was conducted to ascertain how display-dependent timing differences translate into changes in pattern-reversal visual evoked potential (PR-VEP) P100 peak time distributions, using physical measurements, controlled benchmark data, and large-scale routine clinical recordings with cathode ray tube (CRT) and liquid crystal display (LCD) systems.</p><p><strong>Methods: </strong>We analyzed PR-VEP recordings acquired before and after a routine transition from CRT to LCD systems. The study integrated three complementary data sources: photodiode measurements of trigger-to-luminance delay, a benchmark dataset of 10 healthy participants, and a retrospective clinical dataset comprising 1772 waveforms from 915 examinations. Cross-sectional peak time distributions and within-eye paired comparisons were evaluated.</p><p><strong>Results: </strong>Mean trigger-to-luminance delay under the LCD conditions was 13.7 ms. Corresponding prolongation of P100 peak time was observed in the benchmark dataset. In the clinical dataset, the P100 peak time distribution showed a rightward shift (mean difference 12.1 ms, 95% confidence interval 10.45-13.56 ms; Cohen's d = 0.73; p < 0.001). Quantile analysis revealed an approximately constant shift across the distribution. Within-eye longitudinal analyses confirmed that this shift also occurred at the individual level.</p><p><strong>Conclusions: </strong>Display-related timing differences produce a systematic shift in PR-VEP peak time distributions. These findings demonstrate that device-dependent peak time offsets present important implications for clinical interpretation, underscoring needs for device-specific reference considerations in electrophysiological practice. Direct measurement of trigger-to-luminance delay might help estimate clinically relevant peak time shifts caused by hardware replacement.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Correspondence: the 35th International Pupil Colloquium-meeting synopsis.","authors":"Yanjun Chen","doi":"10.1007/s10633-026-10161-3","DOIUrl":"https://doi.org/10.1007/s10633-026-10161-3","url":null,"abstract":"<p><p>The 35th International Pupil Colloquium was held virtually on July 23-24, 2026, and hosted by the Department of Ophthalmology and Visual Sciences at the University of Wisconsin-Madison. Continuing a 60-year tradition of multidisciplinary collaboration, the colloquium brought together researchers from diverse clinical and scientific disciplines to showcase innovative research and emerging discoveries. Twenty accepted abstracts were presented across four scientific sessions, covering melanopsin-driven pupil responses in psychopathology, novel translational applications of pupillography, pupillary testing in visual pathway disorders, pupil oscillations in neurodegenerative and psychiatric diseases, and virtual-reality-based pupil testing. The Loewenfeld Lecture, Pupillary Reactions During the State of Unconsciousness, delivered by Dr. Merlin Larson (University of California, San Francisco), provided a compelling review of the clinical application of hand-held pupillometry in anesthesiology. The colloquium also featured the inaugural mini-symposium, in which leading researchers shared their expertise and perspectives on emerging topics in pupil research, and the Best Trainee Presentation Award to recognize and encourage the next generation of pupil researchers. In addition, participants discussed the ongoing revision of the Standards in Pupillography, including an ISCEV-guided procedural standard and a companion review. The meeting highlighted the continued growth of pupil research while recognizing the need to further strengthen its clinical relevance and broader scientific impact.</p>","PeriodicalId":11207,"journal":{"name":"Documenta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149264004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}